Anti-Human CD20 Therapeutic Antibody (Rituximab)
Recombinant monoclonal antibody to Human CD20. Rituximab (trade names rituximab and rituximab) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells (this should not be confused with pancreatic β- or beta cells). Rituximab destroys B cells and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-016 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD20 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, WB and most other immunological methods. |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |